Idexx Laboratories | IDXX - Equity Capital And Reserves


Idexx Laboratories reported $1.61B in Equity Capital and Reserves for its fiscal quarter ending in June of 2026.





Equity Capital And Reserves Change Date
Abbott USD 52.06B 69M Mar/2026
Accuray USD 53.42M 8.45M Dec/2025
Align Technology USD 4.23B 83.03M Jun/2026
AngioDynamics USD 176.33M 2.52M Sep/2025
Dentsply International USD 1.35B 33M Jun/2026
Dexcom USD 2.62B 335.5M Jun/2026
Edwards Lifesciences USD 10.62B 290.5M Jun/2026
Fujifilm JPY 3.84T 119.25B Mar/2026
Globus Medical USD 4.77B 36.29M Jun/2026
Henry Schein USD 3.16B 109M Jun/2026
Idexx Laboratories USD 1.61B 56.47M Jun/2026
Inogen USD 197.18M 2.32M Sep/2025
Insulet USD 1.42B 119.6M Jun/2026
Integra LifeSciences USD 1.04B 971K Jun/2026
Intuitive Surgical USD 18.17B 693.9M Jun/2026
Neogen USD 2.09B 9.5M Mar/2026
Orthofix International USD 429.18M 6.01M Jun/2026
Phibro Animal Health USD 361.83M 29.47M Mar/2026
ResMed USD 6.59B 93.48M Jun/2026
Roche Holding CHF 32.69B 1.11B Jun/2026
Steris USD 7.21B 23.1M Jun/2026
Tandem Diabetes Care USD 130.39M 2.02M Jun/2026
Teleflex USD 2.9B 179.9M Jun/2026
Thermo Fisher Scientific USD 51.93B 1.6B Mar/2026
Zoetis USD 3.15B 85M Jun/2026